Global Face and Facts of AIDS

Sub-Saharan Africa
Number of people living with HIV 2011 23.5 million
2001 19.7 million
Number of new infections 2011 1.8 million
2001 2.3 million
Number of children newly infected 2011 300,000
2001 460,000
Number of AIDS-related deaths 2011 1.2 million
2001 1.4 million

Sub-Saharan Africa

During the time LHCF has been engaged in providing hope to those living with HIV Sub-Saharan Africa has remained disproportionally impacted by the virus. The largest percentage of new infections occurs in Sub-Saharan Africa and 70% of AIDS related deaths. As the AIDS pandemic ages the number of people living with HIV steadily increases creating a growing need for resources and infrastructure development. The number of new HIV infections has decreased, but not significantly on an annual basis, and Sub-Saharan Africa still represents over 70% of new HIV infections globally, and over 90% of new HIV infections among children. The death rate in Sub-Saharan Africa has only declined slightly and is equivalent to a Boeing 747 with 500 passengers crashing every 3.6 hours every day of the year. Think about it, one plane crash of this magnitude a year would be headline news, over 2400 per year is just unthinkable! AIDS is NOT over.

Although HIV/AIDS are not prominently in the news today as it was 10 year ago, the problem is still as tragic, real, and destructive as ever. There has been much progress with treatment, but the needs still far exceed the availability of resources. LHCF is committed to meeting the needs in unique and personal ways.

The prevalence of HIV in Africa is almost 6 times the global prevalence:

Hope for ending the HIV pandemic currently hinges on effective treatment with antiretroviral drugs. This therapy (Anti-Retroviral Therapy or ART) can help a person live a normal life span, end transmission from mother to child, and is now proven to prevent sexual transmission from one individual to another.

Living Long with HIV

It is now possible with treatment to live nearly a normal life span with HIV. The keys to this benefit are getting tested for HIV early, starting treatment early and staying adherent with ART for life. Currently most people only get tested for HIV when they are sick, so they start late, and face greater challenges with the therapy. Living Hope Clinical Foundation is committed to supporting persons with HIV to get tested early, start treatment early, and stay committed to their ART for life.

Option B+

This is the term currently being used for treating all pregnant HIV+ women with effective antiretroviral therapy for life. This strategy will allow the mother to be healthy for herself and her family, and is the most effective way to prevent mother to child transmission of HIV during pregnancy and breast feeding. Living Hope Clinical Foundation is committed to working with partners to develop successful implementation strategies for Option B+.

Treatment as Prevention

One of the biggest breakthroughs in HIV prevention was the confirmation that effective HIV treatment can prevent new infections in the partners of those infected. HPTN 052 was a study that provided antiretroviral treatment to persons with HIV that had an HIV negative partner. This study demonstrated 96% effectiveness in preventing the transmission of HIV to the HIV negative partner. We now have a proven strategy to bring an end to new HIV infections. Living Hope Clinical Foundation is committed to bringing an end to the HIV pandemic by encouraging universal HIV testing, initiation of early ART, and supporting persons to use all prevention methods available to stop HIV transmission. Living Hope Clinical Foundation is committed to working with communities to develop the strategies and networks to achieve this objective.